Meeting Banner
Abstract #3665

23Na-MRI demonstrates a sodium gradient within gliomas as a biomarker of tumor heterogeneity

Fulvio Zaccagna1, Frank Riemer1, Mary A McLean2, James T. Grist1, Joshua Kaggie1, Rolf Schulte3, Sarah Hilborne1, Tomasz Matys1, Jonathan H. Gillard1, Colin Watts4, Stephen J. Price4, Martin J. Graves1, and Ferdia A. Gallagher1

1Department of Radiology, University of Cambridge, Cambridge, United Kingdom, 2Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom, 3GE Global Research, Munich, Germany, 4Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom

Glioma grade and the extent of local infiltration are important for guiding management. Imaging tumor heterogeneity may improve diagnosis and therapy planning. 23Na-MRI has been used here to demonstrate a gradient in sodium concentration across gliomas: necrosis > viable tissue > edema. This gradient was evident in all the tumors analyzed and is consistent with the expected underlying cellular microstructure where the sodium concentration is dominated by the extracellular fluid in edema and by an absence of cells in the necrotic core. The study provides evidence that 23Na-MRI represents an imaging biomarker of tumor heterogeneity and tissue microstructure in glioma.

This abstract and the presentation materials are available to members only; a login is required.

Join Here